Insider Buying: Cooper Companies (NASDAQ:COO) CEO Purchases $808,000.00 in Stock

The Cooper Companies, Inc. (NASDAQ:COO) CEO Albert White III bought 10,000 shares of the firm’s stock in a transaction that occurred on Tuesday, December 16th. The stock was acquired at an average price of $80.80 per share, for a total transaction of $808,000.00. Following the transaction, the chief executive officer owned 236,151 shares in the company, valued at $19,081,000.80. This trade represents a 4.42% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Cooper Companies Stock Performance

NASDAQ COO opened at $82.46 on Friday. The company has a 50-day simple moving average of $74.41 and a two-hundred day simple moving average of $71.89. The Cooper Companies, Inc. has a 12-month low of $61.78 and a 12-month high of $100.24. The firm has a market cap of $16.16 billion, a price-to-earnings ratio of 43.86, a PEG ratio of 2.35 and a beta of 1.05. The company has a quick ratio of 1.13, a current ratio of 1.89 and a debt-to-equity ratio of 0.30.

Cooper Companies (NASDAQ:COO) last released its earnings results on Thursday, December 4th. The medical device company reported $1.15 earnings per share for the quarter, beating analysts’ consensus estimates of $1.11 by $0.04. The company had revenue of $1.07 billion during the quarter, compared to analyst estimates of $1.06 billion. Cooper Companies had a return on equity of 10.02% and a net margin of 9.16%.Cooper Companies’s revenue for the quarter was up 4.6% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.04 EPS. Cooper Companies has set its FY 2026 guidance at 4.450-4.600 EPS and its Q1 2026 guidance at 1.020-1.040 EPS. On average, equities analysts forecast that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Cooper Companies announced that its Board of Directors has authorized a stock buyback plan on Wednesday, September 17th that authorizes the company to repurchase $2.00 billion in shares. This repurchase authorization authorizes the medical device company to reacquire up to 15.4% of its stock through open market purchases. Stock repurchase plans are typically a sign that the company’s board believes its stock is undervalued.

Analyst Ratings Changes

Several research analysts have recently issued reports on COO shares. Piper Sandler restated an “overweight” rating and issued a $94.00 target price (up previously from $83.00) on shares of Cooper Companies in a report on Friday, December 5th. JPMorgan Chase & Co. boosted their price objective on shares of Cooper Companies from $66.00 to $78.00 and gave the company a “neutral” rating in a research report on Friday, December 5th. Citigroup reiterated a “neutral” rating and set a $88.00 target price (up from $72.00) on shares of Cooper Companies in a report on Monday, December 8th. Wells Fargo & Company raised their target price on Cooper Companies from $72.00 to $82.00 and gave the stock an “equal weight” rating in a research note on Friday, December 5th. Finally, Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Cooper Companies in a research report on Monday. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, five have given a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $90.15.

Institutional Trading of Cooper Companies

Several institutional investors and hedge funds have recently bought and sold shares of the stock. Bell Investment Advisors Inc grew its holdings in shares of Cooper Companies by 106.3% during the 3rd quarter. Bell Investment Advisors Inc now owns 425 shares of the medical device company’s stock worth $29,000 after acquiring an additional 219 shares during the period. GKV Capital Management Co. Inc. purchased a new position in shares of Cooper Companies in the 1st quarter valued at approximately $40,000. J.Safra Asset Management Corp boosted its position in shares of Cooper Companies by 204.8% during the second quarter. J.Safra Asset Management Corp now owns 506 shares of the medical device company’s stock valued at $36,000 after purchasing an additional 340 shares in the last quarter. CYBER HORNET ETFs LLC purchased a new stake in Cooper Companies in the second quarter worth $36,000. Finally, MUFG Securities EMEA plc bought a new position in Cooper Companies in the second quarter worth $42,000. 24.39% of the stock is currently owned by hedge funds and other institutional investors.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.